Monopar Therapeutics Inc. (MNPR)
NASDAQ · Healthcare
Monopar Therapeutics Inc. Shares Outstanding 2016–2025
Monopar Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2016 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Monopar Therapeutics Inc. shares outstanding for the quarter ending March 31, 2026 was 0.01 B shs, a 27.90% decrease year-over-year.
- Monopar Therapeutics Inc. annual shares outstanding for 2025 was 0.01 B shs, a 9.66% increase from 2024.
- Monopar Therapeutics Inc. annual shares outstanding for 2024 was 0.01 B shs, a 42.36% decrease from 2019.
- Monopar Therapeutics Inc. annual shares outstanding for 2019 was 0.01 B shs, a 13.95% increase from 2018.
- Monopar Therapeutics Inc. annual shares outstanding for 2018 was 0.01 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Monopar Therapeutics Inc. Shares Outstanding — FAQ
Monopar Therapeutics Inc. (MNPR) shares outstanding over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Monopar Therapeutics Inc.'s shares outstanding?
Monopar Therapeutics Inc. (MNPR) reported shares outstanding of 0.01B shares for fiscal 2025.
Where can I see MNPR's shares outstanding history?
The chart and table above show Monopar Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.